Henry Schein Stock Fair Value – Henry Schein Stock Soars Wednesday, Outperforming Market
December 7, 2023
🌥️Trending News
Henry Schein ($NASDAQ:HSIC) Inc. is a diversified healthcare company focused on providing value-added services and solutions to dental and medical professionals. On Wednesday, the company’s stock rose to outperform the market, signaling investors’ confidence in its future growth. The surge in stock price was attributed to Henry Schein’s strong financial performance in the most recent quarter.
In addition, the company has made several strategic moves to expand its product offerings and customer base. These advancements have helped it to remain competitive in a rapidly changing industry. With its stock performance on Wednesday, Henry Schein has demonstrated its reliability and stability in the market.
Stock Price
Henry Schein Inc. stock soared on Wednesday, outperforming the market. The stock opened at $69.9 and closed at $70.6, up 1.1% from its prior closing price of $69.9. This stock move offered investors a positive sign for the healthcare services company, and may be poised to continue its growth in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Henry Schein. More…
| Total Revenues | Net Income | Net Margin |
| 12.69k | 445 | 4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Henry Schein. More…
| Operations | Investing | Financing |
| 653 | -276 | -315 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Henry Schein. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 9.15k | 4.14k | 27.26 |
Key Ratios Snapshot
Some of the financial key ratios for Henry Schein are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 9.7% | 12.8% | 5.2% |
| FCF Margin | ROE | ROA |
| 4.2% | 11.7% | 4.6% |
Analysis – Henry Schein Stock Fair Value
GoodWhale has conducted an analysis of Henry Schein’s wellness, and our proprietary Valuation Line has found that the intrinsic value of HENRY SCHEIN share is around $82.8. This means that the current price of the stock, which is $70.6, is undervalued by 14.8%. More…
Peers
Henry Schein Inc is one of the largest companies in the dental supplies industry.
However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.
– Healthlead PCL ($SET:HL)
LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.
– Patterson Companies Inc ($NASDAQ:PDCO)
Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.
– Alfresa Holdings Corp ($TSE:2784)
Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.
Summary
Henry Schein, Inc. (HSIC) has seen a positive stock price increase on Wednesday, outperforming the market. Investors have been attracted to the company’s solid financials, strong sales growth, and diversified revenue streams. Henry Schein has a strong balance sheet and cash flow, providing increased flexibility in funding operations.
Additionally, the impressive long-term growth prospects from its diverse businesses are encouraging investors. The company’s expanding global presence has enabled it to capitalize on international opportunities, particularly in the emerging markets. All these factors have resulted in positive investor sentiment surrounding Henry Schein, making it an attractive investment option in the long-term.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
